Biomarkers and mechanisms of drug-induced vascular injury in non-rodents

Toxicologic Pathology
C LoudenR Richardson

Abstract

In preclinical safety studies, drug-induced vascular injury can negatively impact candidate-drug selection because there are no obvious diagnostic markers for monitoring this pathology preclinically or clinically. Furthermore, our current understanding of the pathogenesis of this lesion is limited. While vasodilatation and increased shear stress appear to play a role, the exact mechanism(s) of injury to the primary target cells, smooth muscle (SMC) and endothelial cell (EC), are unknown. Evaluation of potential novel markers for clinical monitoring with a mechanistic underpinning would add value in risk assessment and risk management. This mini review focuses on the efforts and progress to identify diagnostic markers as well as understanding the mechanism of action in nonrodent drug-induced vascular injury.

References

Jan 1, 1992·Critical Reviews in Toxicology·P DogteromG K Reznik
Feb 21, 1992·Cell·K G RothbergR G Anderson
Nov 22, 1991·Science·P CuevasG Giménez-Gallego
Jan 1, 1989·Toxicologic Pathology·G M MesfinG R Zins
Nov 1, 1989·American Journal of Obstetrics and Gynecology·J M RobertsM K McLaughlin
Jan 1, 1989·Toxicologic Pathology·J T Sobota
Jan 1, 1989·Toxicologic Pathology·C J SchwartzE H Edwards
Jan 1, 1989·Toxicologic Pathology·K R IsaacsG R Betton
Jan 1, 1987·Toxicologic Pathology·G M MesfinM J Higgins
Nov 1, 1984·Journal of Cardiovascular Pharmacology·S J Humphrey, G R Zins
Aug 1, 1993·Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology·G E SanduskyH K Yeager
Jun 1, 1996·The Journal of Surgical Research·M D HariawalaJ F Symes
Jan 1, 1996·Journal of Molecular and Cellular Cardiology·S P BishopS F Vatner
Jun 1, 1996·Journal of Cardiovascular Pharmacology·R YangH Jin
Feb 6, 1998·Home Care Provider·J Hafkenschiel
May 22, 1998·Journal of Cardiovascular Pharmacology·C LoudenH A Solleveld
Jun 3, 1998·Toxicologic Pathology·M A AlbassamG E Macallum
Oct 6, 1998·Annual Review of Biochemistry·R G Anderson
Jul 13, 1999·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·M HaasJ R Thistlethwaite
Jan 20, 2000·Journal of Medicinal Chemistry·L F HennequinC Lambert-van der Brempt
Mar 18, 2000·Toxicology Letters·M Stephan-Gueldner, A Inomata
Apr 6, 2000·American Journal of Physiology. Heart and Circulatory Physiology·H ParkH Jo
Jul 6, 2000·The American Journal of Pathology·C S LoudenL W Schwartz
Oct 12, 2000·Toxicologic Pathology·S J NewsholmeL W Schwartz
Feb 7, 2001·Circulation Research·O Feron, R A Kelly
Feb 13, 2001·Kidney International. Supplement·J T KielsteinR H Böger
Feb 24, 2001·Lancet·J M Roberts, D W Cooper
Dec 26, 2001·Journal of the American Society of Nephrology : JASN·Jan T KielsteinDanilo Fliser
Feb 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·Deirdre P McIntoshJan E Schnitzer
Jun 13, 2002·American Journal of Physiology. Renal Physiology·Michael S GoligorskyJun Chen
Aug 15, 2002·Proceedings of the National Academy of Sciences of the United States of America·You-Yang ZhaoKenneth R Chien
Aug 22, 2002·The Journal of Biological Chemistry·Pingsheng LiuRichard G W Anderson

❮ Previous
Next ❯

Citations

Jan 25, 2012·Journal of Toxicologic Pathology·Robert A EttlinDavid E Prentice
May 26, 2012·Toxicology and Applied Pharmacology·Roberta A ThomasHeath C Thomas
Oct 11, 2011·Toxicology and Applied Pharmacology·Deidre A DalmasHeath C Thomas
Jun 21, 2011·Journal of Pharmacological and Toxicological Methods·Cristian T BadeaG Allan Johnson
Jan 1, 2007·Drug Discovery Today. Technologies·Federico M GoodsaidWilliam Mattes
Jan 16, 2007·Vascular Pharmacology·Belay Tesfamariam, Albert F DeFelice
Feb 11, 2011·British Journal of Pharmacology·Hg LavertyJp Valentin
Apr 30, 2014·Journal of Applied Toxicology : JAT·Varun Ahuja, Sharad Sharma
Oct 13, 2015·Scientific Reports·Youngmee JungKam W Leong
Dec 22, 2007·Toxicologic Pathology·Sabine RehmRogely W Boyce
Apr 17, 2020·Toxicological Sciences : an Official Journal of the Society of Toxicology·Philip MillikenPeter Clements
Sep 14, 2016·Journal of Toxicologic Pathology·Brian R BerridgeMonique Y Wells
Mar 30, 2017·Proceedings of the National Academy of Sciences of the United States of America·Helena VazãoLino Ferreira
Apr 16, 2019·Journal of Medicinal Chemistry·Joey L MethotJason D Katz
Dec 19, 2020·ACS Medicinal Chemistry Letters·Joey L MethotJason D Katz

❮ Previous
Next ❯

Methods Mentioned

BETA
SMA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Toxicology and Applied Pharmacology
D BrottC Louden
Toxicology and Applied Pharmacology
William KernsExpert Working Group on Drug-Induced Vascular Injury
Journal of Pharmacological and Toxicological Methods
Roberta A ThomasKendall S Frazier
© 2021 Meta ULC. All rights reserved